112 related articles for article (PubMed ID: 83917)
1. Demonstration of tube leukocyte adherence inhibition assay with coded samples of blood.
Thomson DM
Cancer Res; 1979 Feb; 39(2 Pt 2):627-9. PubMed ID: 83917
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of the microtest version of the leukocyte adherence inhibition assay.
Goldrosen MH; Howell JH; Holyoke ED
Cancer Res; 1979 Feb; 39(2 Pt 2):630-2. PubMed ID: 367588
[TBL] [Abstract][Full Text] [Related]
3. Hemocytometer leukocyte adherence inhibition technique.
Maluish AE; Halliday WJ
Cancer Res; 1979 Feb; 39(2 Pt 2):625-6. PubMed ID: 83916
[TBL] [Abstract][Full Text] [Related]
4. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Mr 40,000 polypeptide from colorectal cancer which expresses organ-specific cancer neoantigen activity as determined by leukocyte adherence inhibition.
Artigas C; Thomson DM; Durko M; Sutherland M; Scanzano R; Shenouda G; Dubois AE
Cancer Res; 1986 Apr; 46(4 Pt 1):1874-81. PubMed ID: 2418955
[TBL] [Abstract][Full Text] [Related]
6. Organ specific neoantigens reactive in the leukocyte adherence inhibition assay: affinity purification of human colon carcinoma antigen and its cross-reactive protein using monoclonal antibodies.
Hadas E; Fink A; Gembom E; Harpaz N; Shani A; Bentwich Z; Eshhar Z
Cancer Res; 1986 Oct; 46(10):5201-5. PubMed ID: 2428475
[TBL] [Abstract][Full Text] [Related]
7. Characterization of murine tumor-associated antigens by the micro-leukocyte adherence inhibition assay.
Howell JH; Russo AJ; Goldrosen MH
Cancer Res; 1979 Feb; 39(2 Pt 2):612-8. PubMed ID: 83914
[No Abstract] [Full Text] [Related]
8. [Study on the tumor immunity of renal cell carcinoma--with special reference to the significance of leukocyte adherence inhibition test].
Okada Y
Hinyokika Kiyo; 1984 Oct; 30(10):1367-77. PubMed ID: 6395679
[TBL] [Abstract][Full Text] [Related]
9. Experiences with leukocyte adherence inhibition in human cancer.
Maluish AE
Cancer Res; 1979 Feb; 39(2 Pt 2):644-8. PubMed ID: 367590
[No Abstract] [Full Text] [Related]
10. Evaluation of micro-leukocyte adherence inhibition as an immunodiagnostic test for pancreatic cancer.
Goldrosen MH; Russo AJ; Howell JH; Leveson SH; Moore MC; Holyoke ED; Douglass HO
Cancer Res; 1979 Feb; 39(2 Pt 2):633-7. PubMed ID: 367589
[No Abstract] [Full Text] [Related]
11. Evaluation of the microleukocyte adherence inhibition assay as an immunodiagnostic test for pancreatic cancer.
Russo AJ; Douglass HO; Leveson SH; Howell JH; Holyoke ED; Harvey SR; Chu TM; Goldrosen MH
Cancer Res; 1978 Jul; 38(7):2023-9. PubMed ID: 77724
[No Abstract] [Full Text] [Related]
12. Specific immunodiagnosis of hepatoma by tube leukocyte adherence inhibition assay and a modified method of repeated tube leukocyte adherence inhibition assay.
Morizane T; Kumagai N; Tsuchimoto K; Watanabe T; Tsuchiya M
Cancer Res; 1980 Aug; 40(8 Pt 1):2928-34. PubMed ID: 6248217
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
[TBL] [Abstract][Full Text] [Related]
14. Tube leukocyte adherence inhibition (LAI) assay in gastrointestinal (GIT) cancer.
Tataryn DN; MacFarlane JK; Murray D; Thomson DM
Cancer; 1979 Mar; 43(3):898-912. PubMed ID: 371789
[TBL] [Abstract][Full Text] [Related]
15. [Leukocyte-adherence-inhibition reactivity in patients with colorectal and pancreatic cancer (author's transl)].
Wagner T; Peschel U; Heydrich D; Ritter U
Z Gastroenterol; 1981 Mar; 19(3):140-7. PubMed ID: 7234027
[TBL] [Abstract][Full Text] [Related]
16. An isolated enriched organ-specific cancer neoantigen of human lung cancer for leukocyte adherence inhibition assays.
Dubois AE; Thomson DM; Sutherland ME; Scanzano R
Cancer Res; 1985 Jun; 45(6):2661-9. PubMed ID: 3886136
[TBL] [Abstract][Full Text] [Related]
17. Reversible abnormal nonadherence to glass and responsiveness to chemoattractants of leukocytes from patients with advanced cancer.
Thomson DM
J Natl Cancer Inst; 1984 Sep; 73(3):607-16. PubMed ID: 6088879
[TBL] [Abstract][Full Text] [Related]
18. The need to establish whether the leukocyte adherence inhibition test is a reliable assay of tumor immunity in humans.
Hellström KE; Hellström I
Cancer Res; 1979 Feb; 39(2 Pt 2):649-50. PubMed ID: 83919
[TBL] [Abstract][Full Text] [Related]
19. The isolation of colon cancer organ specific neoantigen by the use of the leukocyte adherence inhibition assay and monoclonal antibodies.
Fink A; Harpaz N; Weisman Z; Shani A; Bentwich Z
Anticancer Res; 1986; 6(4):813-7. PubMed ID: 3752960
[TBL] [Abstract][Full Text] [Related]
20. Sensitization of leukocytes of cancer patients against fetal antigens: leukocyte migration studies.
Zöller M; Matzku S; Schulz U; Price MR
J Natl Cancer Inst; 1979 Aug; 63(2):285-93. PubMed ID: 88534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]